Dr Aasim sehbai -

Overview (Dr. aasim sehbai)

Dr. Aasim Sehbai is a seasoned oncologist based in Anniston, Alabama, with over 20 years of experience in treating various forms of cancer. He is currently affiliated with RMC Anniston, where he leverages his extensive medical knowledge to provide exceptional care to cancer patients. Dr. Sehbai specializes in the treatment of lung cancer, breast cancer, colorectal cancer, and small intestine cancers, among other conditions. He is committed to offering personalized, high-quality care to his patients, utilizing both his clinical expertise and the latest in medical technology.

Dr. Sehbai earned his medical degree from Rawalpindi Medical College in 1997 and has since undergone specialized training in Internal Medicine and Oncology. His extensive experience and qualifications make him a trusted medical professional for individuals seeking expert cancer care.

Specialties

Dr. Aasim S. Sehbai is a highly skilled oncologist specializing in the diagnosis, treatment, and management of a wide variety of cancers. His specialties include:

Lung Cancer
Breast Cancer
Small Intestine/Colorectal Cancer
Other Cancers

As an oncologist, Dr. Sehbai uses various diagnostic tools, including biopsies, endoscopies, X-rays, and imaging, to identify the type and stage of cancer. His expertise in medical oncology involves the use of chemotherapy and other forms of treatment to manage and eradicate cancer cells. He also works closely with radiation oncologists and cancer surgeons to ensure comprehensive care for his patients.

Certifications & Licensure of dr aasim sehbai

Dr. Sehbai has received numerous certifications in multiple specialties, ensuring his expertise in managing complex medical conditions related to oncology and hematology. His certifications include:

American Board of Internal Medicine (ABMS®)
- Certified in Hematology
- Certified in Internal Medicine
- Certified in Medical Oncology
National Board of Physicians and Surgeons
- Certified in Hematology
- Certified in Internal Medicine
- Certified in Medical Oncology
State Medical Licenses
- AL State Medical License (Active through 2025)
- OH State Medical License (Active through 2020)
- DE State Medical License (Active through 2019)
- NC State Medical License (Active through 2018)
- ME State Medical License (Active through 2016)
- WV State Medical License (Active through 2009)
- MD State Medical License (Active through 2025)
- VA State Medical License (Active through 2022)
- SC State Medical License (Active through 2019)

Professional Memberships

Dr. Sehbai is a member of several prestigious organizations that keep him at the forefront of cancer research and treatment. Some of the professional memberships he holds include:

American Society of Clinical Oncology (ASCO)

Education & Training of dr aasim sehbai

Dr. Sehbai’s educational background and professional training are fundamental to his expertise in oncology. His educational journey includes:

Fellowship in Hematology and Medical Oncology
- West Virginia University (2003 – 2006)
Residency in Internal Medicine
- West Virginia University (2000 – 2003)
Medical Degree
- Rawalpindi Medical College (Class of 1997)

Research Contributions of dr aasim sehbai

Emerging trends and disparities in mortality due to coexisting non-Hodgkin’s lymphoma and respiratory infections: A U.S. nationwide retrospective analysis from 1999 to 2020.

Humza Saeed, Masab Ali, Muhammad Husnain Ahmad, Ilsa Babar, Sana Javeria, Zabeehullah, Ch Faizan Rasheed, Hiba Arshad Shahani, Aasim Sehbai

Merkel cell carcinoma in a patient with basal cell carcinoma: a case of localized disease with negative sentinel node biopsy.

Hiba Arshad Shahani, Masab Ali, Ilsa Babar, Sana Javeriya, Muhammad Husnain Ahmad, Humza Saeed, Uswa Ahmad, Aasim Sehbai

Possible Ovarian and Peritoneal Carcinoma Presenting in a Mediastinal Lymph Node and Pleural Effusion: A Case Report and Review of the Literature.

Aasim Sehbai, Nick W Lanpher, Keana-Kelley D Swanner

Unusual presentation of gastric cancer during treatment of hairy cell leukemia: Exploring the etiological basis of this rare phenomenon.

Shahan Tariq, Muhammad Ammar Bin Hamid, Nazia Rahman, Kristine Wong, Aasim Sehbai, Lindsey Oleary

COVID-19 Vaccination in<br /> Pregnant Women: Exploring Serious Adverse Events.

Shahan Tariq, Muhammad Ammar Bin Hamid, Aasim Sehbai

Pembrolizumab-Induced Lichen Planus in a Patient With Non-Small-Cell Lung Carcinoma (NSCLC) That Correlates to Therapeutic Response.

Aasim Sehbai, Muhammad A Hamid, Zainab Ibrahim

Recurrence Risk of Renal Cell Carcinoma Lingers Even Decades After Nephrectomy.

Muhammad Ammar B. Hamid, Aasim S. Sehbai, Shahan Tariq, Sana Ullah

Ischemic Stroke in a Young Man: Unraveling the Domain of Myeloproliferative Disorders.

Muhammad Ammar B. Hamid, Aasim S. Sehbai, Shahan Tariq

Cancer health disparities among Indian and Pakistani immigrants in the United States: a Surveillance, Epidemiology, and End Results-based study from 1988 to 2003.

Akm Hossain, Aasim S. Sehbai, Rachel Abraham, Jame Abraham

Correlation among [18F]fluorodeoxyglucose positron emission tomography/computed tomography, cancer antigen 27.29, and circulating tumor cell testing in metastatic breast cancer.

Ayman Saad, Abraham S. Kanate, Aasim Sehbai, Gary Marano, Gerry Hobbs, Jame Abraham

A study of US-based Indian and Pakistani population with cancer diagnosis reported in the SEER database from 1988 to 2002.

Hossain A, Sehbai A, Abraham J

Epidemiologic characteristics of colon cancer in Asian Indian and Pakistani population living in the USA compared to US White population in SEER database from 1988 to 2002.

Sehbai AS, Hossain A, Kurian S, Abraham J

Correlation of CD3 and CD34 cell dose with incidence of acute GVHD in myeloablative stem cell transplantation.

Saad A, Visweshwar N, Sehbai A, Cumpston A, Watkins K, Buckhalter R, Hobbs G, Abraham J, Ericson S

Epidemiologic characteristics of breast cancer (BC) in Asian Indian and Pakistani population living in the US compared to US white population in SEER database from 1988 to 2002.

Abraham J, Hossain A, Sehbai A

Thymic Hyperplasia after Adjuvant Chemotherapy in Breast Cancer

Aasim S. Sehbai, Robert J. Tallaksen, Jason Bennett, Jame Abraham

Perioperative management of a patient with May–Hegglin anomaly requiring craniotomy

Aasim S. Sehbai, Jame Abraham, Vidya K. Brown

Rhabdomyolysis and Renal Failure Associated with Gemfibrozil Monotherapy

Richard D. Layne, Aasim S. Sehbai, Linda J Stark

Commitment to Patient Care

Dr. Sehbai’s practice is rooted in a deep commitment to providing the best possible care for his patients. His approach is highly personalized, offering treatments based on the latest research and medical advancements. He uses his vast clinical knowledge to create treatment plans that are customized to each patient’s specific cancer type and stage, ensuring the best possible outcomes.

Dr. Sehbai’s patients benefit not only from his medical expertise but also from his compassionate care and attention to their overall well-being. He offers comprehensive cancer management, from diagnosis and treatment to follow-up care, ensuring that each patient is supported throughout their treatment journey.

Leadership Roles

Dr. Sehbai currently serves as the President of Salam Clinic Anniston (2019 – 2024), where he provides leadership and direction in promoting healthcare excellence and supporting the local community’s healthcare needs.

Accepted Insurance Plans

Dr. Sehbai accepts a wide range of insurance plans, ensuring that more patients have access to his expertise. Some of the major insurance providers include:

Aetna
Humana
Cigna
Blue Cross
United Healthcare
And many more